Inflammasomes as potential mediators of adverse cardiovascular events in diabetes and lupus: more questions than answers
J Cardiovasc Med (Hagerstown)
.
2023 May 1;24(5):279-282.
doi: 10.2459/JCM.0000000000001448.
Authors
Angel López-Candales
1
,
Khalid Sawalha
2
,
Luis M Vila
3
Affiliations
1
Section of Cardiovascular Medicine, University Health, Truman Medical Center, University of Missouri-Kansas City.
2
University of Missouri-Kansas City, Nutrition and Metabolism Fellowship, Kansas City, Missouri, USA.
3
Division of Rheumatology, Allergy, and Immunology, University of Puerto Rico Medical School, San Juan, Puerto Rico.
PMID:
37016797
DOI:
10.2459/JCM.0000000000001448
No abstract available
Publication types
Editorial
MeSH terms
Cardiovascular Diseases* / diagnosis
Cardiovascular Diseases* / etiology
Cardiovascular System*
Diabetes Mellitus* / diagnosis
Heart
Humans
Inflammasomes
Substances
Inflammasomes